C-reactive protein levels: a prognostic marker for patients with head and neck cancer?
By: Astrid L Kruse , Heinz T Luebbers and Klaus W Graetz

Head & Neck Oncology 2010, 2:21 doi:10.1186/1758-3284-2-21
Published: 2 August 2010

Abstract (Provisional)

Background

Recent advances in understanding complex tumor interactions have led to the discovery of an association between inflammation and cancer, in particular for colon and lung cancer, but only a very few have dealt with oral cancer. Therefore, the aim of the current study was to investigate the significance of preoperative CRP levels as a parameter for development of lymph node metastases or recurrence.

Material and methods

In 278 patients with oral cancer, preoperative CRP levels were compared with development of recurrence and metastasis.

Results

In 27 patients from the normal CRP group, and in 21 patients from the elevated CRP group, local recurrence was observed. Concerning lymph node metastases, 37 patients were in the normal group and 9 patients in the elevated CRP group. No significant correlation could be found between elevated CRP levels and metastasis (p=0.468) or recurrence (p=0.137).

Conclusion

Our findings do not appear to support a correlation between preoperative CRP levels and development of recurrence or metastases. In further studies, CRP levels in precancerous lesions and in HPV positive patients with oral SCC should be studied.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production







Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements